236 related articles for article (PubMed ID: 18463325)
21. Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.
Wang J; Hu W; Xie H; Zhang H; Chen H; Zeng C; Liu Z; Li L
Lupus; 2007; 16(9):707-12. PubMed ID: 17728363
[TBL] [Abstract][Full Text] [Related]
22. [Mycophenolate mofetil in high risk IgA glomerulonephritis].
Frutos MA; López V; Alférez MJ; Aranda P
Nefrologia; 2005; 25(4):387-92. PubMed ID: 16231504
[TBL] [Abstract][Full Text] [Related]
23. Pneumocystis carinii pneumonia in patients with connective tissue disease.
Li J; Huang XM; Fang WG; Zeng XJ
J Clin Rheumatol; 2006 Jun; 12(3):114-7. PubMed ID: 16755237
[TBL] [Abstract][Full Text] [Related]
24. Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide.
Branten AJ; du Buf-Vereijken PW; Vervloet M; Wetzels JF
Am J Kidney Dis; 2007 Aug; 50(2):248-56. PubMed ID: 17660026
[TBL] [Abstract][Full Text] [Related]
25. Red blood cell anemia in a patient with pemphigus vulgaris induced by the use of mycophenolate mofetil and prednisone.
Scheinfeld N
J Dermatolog Treat; 2007; 18(4):243-5. PubMed ID: 17671884
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial.
Hou FF; Xie D; Wang J; Xu X; Yang X; Ai J; Nie S; Liang M; Wang G; Jia N;
JAMA Netw Open; 2023 Feb; 6(2):e2254054. PubMed ID: 36745456
[TBL] [Abstract][Full Text] [Related]
27. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
[TBL] [Abstract][Full Text] [Related]
28. [Mycophenolate mofetil in the treatment of primary nephrotic syndrome].
Zhao M; Chen X; Chen Y; Liu Z; Liu Y; Lu F; Zhang Y; Wang H
Zhonghua Yi Xue Za Zhi; 2001 May; 81(9):528-31. PubMed ID: 11809115
[TBL] [Abstract][Full Text] [Related]
29. Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy. A follow-up study by the Spanish Cooperative Study Group of Chronic Allograft Nephropathy.
Gonzalez Molina M; Seron D; Garcia del Moral R; Carrera M; Sola E; Jesus Alferez M; Gomez Ullate P; Capdevila L; Gentil MA
Transplantation; 2004 Jan; 77(2):215-20. PubMed ID: 14742984
[TBL] [Abstract][Full Text] [Related]
30. A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis.
Hlivko JT; Shiffman ML; Stravitz RT; Luketic VA; Sanyal AJ; Fuchs M; Sterling RK
Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1036-40. PubMed ID: 18586559
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of immunosuppressive therapies in the treatment of high-risk IgA nephropathy: A network meta-analysis.
Liu T; Wang Y; Mao H; Yang L; Zhan Y
Medicine (Baltimore); 2021 Feb; 100(8):e24541. PubMed ID: 33663060
[TBL] [Abstract][Full Text] [Related]
32. Mycophenolate mofetil treatment for IgA nephropathy: a meta-analysis.
Xu G; Tu W; Jiang D; Xu C
Am J Nephrol; 2009; 29(5):362-7. PubMed ID: 18974636
[TBL] [Abstract][Full Text] [Related]
33. Sequential therapies for proliferative lupus nephritis.
Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
[TBL] [Abstract][Full Text] [Related]
34. [A prospective multicenter clinical control trial on treatment of refractory nephrotic syndrome with mycophenolate mofetil in children].
Yi ZW; Wu XC; Xu H; Zhou LJ; Wu YB; Feng SP; Zhou JH; Yang Q; Zhu GH; Liu AM; Wei MJ; Yu L; Zeng ZF
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):575-8. PubMed ID: 18947472
[TBL] [Abstract][Full Text] [Related]
35. Long-term study of mycophenolate mofetil treatment in IgA nephropathy.
Tang SC; Tang AW; Wong SS; Leung JC; Ho YW; Lai KN
Kidney Int; 2010 Mar; 77(6):543-9. PubMed ID: 20032964
[TBL] [Abstract][Full Text] [Related]
36. Mycophenolate mofetil for the treatment of scleritis.
Sen HN; Suhler EB; Al-Khatib SQ; Djalilian AR; Nussenblatt RB; Buggage RR
Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
[TBL] [Abstract][Full Text] [Related]
37. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
[TBL] [Abstract][Full Text] [Related]
38. Treatment of IgA nephropathy: corticosteroids, tonsillectomy, and mycophenolate mofetil.
Kawamura T
Contrib Nephrol; 2007; 157():37-43. PubMed ID: 17495435
[TBL] [Abstract][Full Text] [Related]
39. Mycophenolate mofetil in liver transplantation.
McDiarmid SV
Clin Transplant; 1996 Feb; 10(1 Pt 2):140-5. PubMed ID: 8680052
[TBL] [Abstract][Full Text] [Related]
40. Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil.
Chandrakantan A; Ratanapanichkich P; Said M; Barker CV; Julian BA
Nephrol Dial Transplant; 2005 Jun; 20(6):1214-21. PubMed ID: 15797890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
